We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Nobel Prize Awarded for Fundamental Discoveries About G-protein-Coupled Receptors and Cellular Signaling

By LabMedica International staff writers
Posted on 16 Oct 2012
Print article
Image: 2012 Chemistry Nobel laureate Prof. Robert J. Lefkowitz (Photo courtesy of the American Society for Pharmacology and Experimental Therapeutics).
Image: 2012 Chemistry Nobel laureate Prof. Robert J. Lefkowitz (Photo courtesy of the American Society for Pharmacology and Experimental Therapeutics).
Image: 2012 Chemistry Nobel laureate Prof. Brian K. Kobilka (Photo courtesy of the Nobel Foundation).
Image: 2012 Chemistry Nobel laureate Prof. Brian K. Kobilka (Photo courtesy of the Nobel Foundation).
The 2012 Nobel Prize for Chemistry jointly awarded to scientists Robert J. Lefkowitz and Brian K. Kobilka recognizes the discovery of G-protein-coupled receptors (GPCRs) and fundamental discoveries about their molecular structure, functional roles, and signaling mechanisms. The prize also reflects recognition that much progress made in medical therapy has been specifically based on knowledge about this large family of signaling receptors.

Until the mid-20th century, scientists only knew that certain molecules, such as hormones, in some way enabled cells to sense certain environmental conditions and initiate powerful biological effects. It was suspected that cell surfaces contained some kind of receptors for these extracellular molecules, but what they consisted of and how they functioned remained obscure. Prof. Lefkowitz, currently a Howard Hughes Medical Institute (Chevy Chase, MD, USA) investigator and professor at Duke University Medical Center (Durham, NC, USA), began by using radioactive, iodine isotope labeled hormones to trace cell surface receptors. By 1968, his team unveiled several receptors, among them the β-adrenergic receptor for adrenalin, which the team extracted from the cell membrane and gained an initial understanding of how it works.

The team achieved its next big step during the 1980s. The newly recruited Brian Kobilka, now professor at Stanford University School of Medicine (Stanford, CA, USA), accepted and, with a creative approach, succeeded in the challenge to isolate from the human genome and sequence the gene for the β-adrenergic receptor. They and other researchers eventually discovered that there is a large family of similar receptors, commonly referred to as the GPCR related family (less commonly, the 7TM [7 transmembrane] receptor family). Over a thousand known genes presently make up this family and include receptors for light, taste, odor, adrenalin, histamine, dopamine, and serotonin. In addition to regulation by ligand molecules, other researchers have found a few GPCRs that are also highly regulated by voltage change signals, such as the voltage-dependent regulation of at least two GPCRs involved in the fast-kinetics form of neurotransmitter release, the M2-muscarinic receptor (M2R) in acetylcholine release and the glutamatergic receptor (e.g., mGluR3) in glutamate release. More recently, by 2011, the research team led by Prof. Kobilka achieved another challenging breakthrough – they captured a structural image of the β-adrenergic receptor at the moment of hormone activation.

Prof. Lefkowitz’s laboratory also discovered two families of proteins that desensitize GPCRs, the GPCR kinases (GRKs) and the arrestins; a finding that has helped scientists understand how receptors become tolerant to certain drugs. About doing research, Prof. Lefkowitz says it "continuously renews itself and always feels fresh. I come to work every day with a sense of great anticipation and curiosity about what new discoveries and insights will come our way." The studies by Prof. Lefkowitz and Prof. Kobilka have turned out to be crucial for understanding how GPCRs function as well as for advancement of medical therapy - many important pharmaceutical drugs achieve their effects through GPCRs due to the critical roles of these receptors in almost all physiological processes.

Related Links:

Duke University Medical Center
Howard Hughes Medical Institute
Stanford University School of Medicine


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.